Literature DB >> 9361921

Graft-versus-host disease after liver and small bowel transplantation in a child.

J Reyes1, S Todo, M Green, E Yunis, D Schoner, S Kocoshis, H Furukawa, K Abu-Elmagd, A Tzakis, J Bueno, T E Starzl.   

Abstract

An 8-month-old child with an immunodeficiency disorder characterized by abnormal lymphocyte function and by low IgG and IgA levels had combined liver and small bowel transplantation under tacrolimus and steroid immunosuppression for the treatment of short gut syndrome and hepatic cirrhosis. The patient developed an early postoperative episode of Pneumocystis carinii pneumonia, and a subsequent surgical complication, prompting discontinuance of tacrolimus. A skin rash eventually shown to be graft-versus-host disease (GVHD) developed in the flank on the 12th post-transplant day and gradually became generalized. Peritonitis, sepsis, multisystem organ failure including the liver allograft led to death on the 23rd post-operative day. The mechanisms leading to post-transplant GVHD under the specific circumstances in this case are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9361921      PMCID: PMC2967285     

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  13 in total

Review 1.  Cell migration, chimerism, and graft acceptance.

Authors:  T E Starzl; A J Demetris; N Murase; S Ildstad; C Ricordi; M Trucco
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

2.  Graft-versus-host disease after clinical small bowel/liver transplantation.

Authors:  D Grant; B Garcia; W Wall; D Oheme-Fianko; R Zhong; R Mimeault; F Sutherland; J Duff
Journal:  Transplant Proc       Date:  1990-12       Impact factor: 1.066

3.  Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506.

Authors:  N Murase; A J Demetris; T Matsuzaki; A Yagihashi; S Todo; J Fung; T E Starzl
Journal:  Surgery       Date:  1991-07       Impact factor: 3.982

4.  Transplantation of small bowel in the rat: technical and immunological considerations.

Authors:  G J Monchik; P S Russell
Journal:  Surgery       Date:  1971-11       Impact factor: 3.982

Review 5.  Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance.

Authors:  T E Starzl; A J Demetris; M Trucco; N Murase; C Ricordi; S Ildstad; H Ramos; S Todo; A Tzakis; J J Fung
Journal:  Hepatology       Date:  1993-06       Impact factor: 17.425

6.  Isohemagglutinins of graft origin after ABO-unmatched liver transplantation.

Authors:  G Ramsey; J Nusbacher; T E Starzl; G D Lindsay
Journal:  N Engl J Med       Date:  1984-11-01       Impact factor: 91.245

7.  Liver transplantation.

Authors:  J S Najarian; N L Ascher
Journal:  N Engl J Med       Date:  1984-11-01       Impact factor: 91.245

Review 8.  Management of acute graft-versus-host disease.

Authors:  H J Deeg; P J Henslee-Downey
Journal:  Bone Marrow Transplant       Date:  1990-07       Impact factor: 5.483

Review 9.  The many faces of multivisceral transplantation.

Authors:  T E Starzl; S Todo; A Tzakis; M Alessiani; A Casavilla; K Abu-Elmagd; J J Fung
Journal:  Surg Gynecol Obstet       Date:  1991-05

10.  Intestinal transplantation in composite visceral grafts or alone.

Authors:  S Todo; A G Tzakis; K Abu-Elmagd; J Reyes; K Nakamura; A Casavilla; R Selby; B M Nour; H Wright; J J Fung
Journal:  Ann Surg       Date:  1992-09       Impact factor: 12.969

View more
  8 in total

1.  Hepatic and intestinal transplantation at the University of Pittsburgh.

Authors:  K Abu-Elmagd; J Fung; J Reyes; A Rao; A Jain; G Mazariegos; W Marsh; J Madariaga; I Dvorchik; J Bueno; J Rogers; J McMichael; F Dodson; H Vargus; J Martin; A Slivka; V Balan; R Corry; J Rakela; N Murase; J Demetris; S Iwatsuki; T Starzl
Journal:  Clin Transpl       Date:  1998

Review 2.  How I treat common variable immune deficiency.

Authors:  Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2010-03-23       Impact factor: 22.113

3.  Clinical intestinal transplantation: new perspectives and immunologic considerations.

Authors:  K Abu-Elmagd; J Reyes; S Todo; A Rao; R Lee; W Irish; H Furukawa; J Bueno; J McMichael; A T Fawzy; N Murase; J Demetris; J Rakela; J J Fung; T E Starzl
Journal:  J Am Coll Surg       Date:  1998-05       Impact factor: 6.113

4.  Graft versus host disease following small bowel and abdominal wall transplantation.

Authors:  Gurdeep S Mannu; Anil Vaidya
Journal:  BMJ Case Rep       Date:  2014-10-06

5.  Clinical intestinal transplantation: a decade of experience at a single center.

Authors:  K Abu-Elmagd; J Reyes; G Bond; G Mazariegos; T Wu; N Murase; R Sindhi; D Martin; J Colangelo; M Zak; D Janson; M Ezzelarab; I Dvorchik; M Parizhskaya; M Deutsch; A Demetris; J Fung; T E Starzl
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

6.  Current status of intestinal transplantation in children.

Authors:  J Reyes; J Bueno; S Kocoshis; M Green; K Abu-Elmagd; H Furukawa; E M Barksdale; S Strom; J J Fung; S Todo; W Irish; T E Starzl
Journal:  J Pediatr Surg       Date:  1998-02       Impact factor: 2.545

Review 7.  The concept of gut rehabilitation and the future of visceral transplantation.

Authors:  Kareem Abu-Elmagd
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-01-20       Impact factor: 46.802

8.  Whole-exome sequencing identifies tetratricopeptide repeat domain 7A (TTC7A) mutations for combined immunodeficiency with intestinal atresias.

Authors:  Rui Chen; Silvia Giliani; Gaetana Lanzi; George I Mias; Silvia Lonardi; Kerry Dobbs; John Manis; Hogune Im; Jennifer E Gallagher; Douglas H Phanstiel; Ghia Euskirchen; Philippe Lacroute; Keith Bettinger; Daniele Moratto; Katja Weinacht; Davide Montin; Eleonora Gallo; Giovanna Mangili; Fulvio Porta; Lucia D Notarangelo; Stefania Pedretti; Waleed Al-Herz; Wasmi Alfahdli; Anne Marie Comeau; Russell S Traister; Sung-Yun Pai; Graziella Carella; Fabio Facchetti; Kari C Nadeau; Michael Snyder; Luigi D Notarangelo
Journal:  J Allergy Clin Immunol       Date:  2013-07-04       Impact factor: 14.290

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.